Detection of Salivary Interleukin 2 and Interleukin 6 in Patients With Burning Mouth Syndrome
Open Access
- 1 January 2006
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2006 (1) , 54632
Abstract
The etiology of BMS remains unknown. Role of various cytokines has been implicated in the development of BMS. The aim of this study was to evaluate levels of salivary IL‐2 and IL‐6 in patients with BMS, compared with age‐matched healthy volunteers (control group). Whole saliva from 30 patients with BMS, age range 55–65, was tested for the presence of IL‐6 and IL‐2 by enzyme immunoassay. Control group consisted of 30 healthy participants, aged 55–65 years. Saliva IL‐2 concentrations in BMS were significantly increased in patients compared to healthy subjects: mean 34.1 ± 9.7 versus 7.3 ± 3.0 pg/mL; P < .001. Patients with BMS had significantly higher concentrations of IL‐6 compared to control: mean 30.8 ± 5.6 versus 5.2 ± 2.8 pg/mL; P < .001. In patients with BMS, IL‐2 and IL‐6 levels in saliva are elevated, correlating with the severity of illness.Keywords
Funding Information
- Ministry of Science and Technology, Republic of Croatia (0062058)
This publication has 17 references indexed in Scilit:
- Personality Disorders in Patients with Burning Mouth SyndromeJournal of Personality Disorders, 2005
- Mechanisms associated with unusual orofacial pain.2005
- The diagnosis of burning mouth syndrome represents a challenge for clinicians.2005
- Stomatodynia (burning mouth) as a complication of enalapril therapyOral Diseases, 2004
- Posttraumatic stress disorder: psychopathology, medical management, and dental implicationsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2004
- Stomatodynia or burning mouth syndrome.2003
- Burning mouth (syndrome) disorder.2003
- [Clinical manifestations of the mouth revealing Vitamin B12 deficiency before the onset of anemia].2003
- Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary studyClinical Oral Investigations, 2001
- [Orofacial idiopathic pain: clinical signs, causes and mechanisms].2001